tradingkey.logo

Nanovibronix Inc

NAOV

5.990USD

-0.335-5.30%
取引時間 ET15分遅れの株価
471.63K時価総額
損失額直近12ヶ月PER

Nanovibronix Inc

5.990

-0.335-5.30%
詳細情報 Nanovibronix Inc 企業名
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
企業情報
企業コードNAOV
会社名Nanovibronix Inc
上場日Apr 24, 2015
最高経営責任者「CEO」Dr. Doron Besser, M.D.
従業員数15
証券種類Ordinary Share
決算期末Apr 24
本社所在地969 Pruitt Piace
都市TYLER
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号75703
電話番号19142333004
ウェブサイトhttps://nanovibronix.com/
企業コードNAOV
上場日Apr 24, 2015
最高経営責任者「CEO」Dr. Doron Besser, M.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
348.00
--
Mr. Christopher M. Fashek
Mr. Christopher M. Fashek
Independent Chairman of the Board
Independent Chairman of the Board
34.00
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Martin S. Goldstein, M.D.
Dr. Martin S. Goldstein, M.D.
Independent Director
Independent Director
--
--
Mr. Thomas R. Mika
Mr. Thomas R. Mika
Independent Director
Independent Director
--
-100.00%
Mr. Brian M. Murphy
Mr. Brian M. Murphy
Director
Director
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
348.00
--
Mr. Christopher M. Fashek
Mr. Christopher M. Fashek
Independent Chairman of the Board
Independent Chairman of the Board
34.00
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Martin S. Goldstein, M.D.
Dr. Martin S. Goldstein, M.D.
Independent Director
Independent Director
--
--
Mr. Thomas R. Mika
Mr. Thomas R. Mika
Independent Director
Independent Director
--
-100.00%
Mr. Brian M. Murphy
Mr. Brian M. Murphy
Director
Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
United States
986.00K
96.20%
New Zealand
19.00K
1.85%
Other
11.00K
1.07%
Europe
9.00K
0.88%
事業別
地域別
データなし
株主
更新時刻: Fri, Aug 29
更新時刻: Fri, Aug 29
株主統計
種類
株主統計
株主統計
比率
Alpha Capital Aktiengesellschaft
0.95%
Armistice Capital LLC
0.46%
UBS Financial Services, Inc.
0.16%
Citi Investment Research (US)
0.03%
Tower Research Capital LLC
0.03%
他の
98.38%
株主統計
株主統計
比率
Alpha Capital Aktiengesellschaft
0.95%
Armistice Capital LLC
0.46%
UBS Financial Services, Inc.
0.16%
Citi Investment Research (US)
0.03%
Tower Research Capital LLC
0.03%
他の
98.38%
種類
株主統計
比率
Holding Company
0.95%
Hedge Fund
0.48%
Investment Advisor
0.16%
Research Firm
0.04%
他の
98.37%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
26
142.96K
5.53%
+80.02K
2025Q1
26
100.49K
7.64%
+70.73K
2024Q4
29
390.46K
7.75%
-206.57K
2024Q3
31
421.26K
15.22%
+83.76K
2024Q2
31
243.60K
8.84%
-214.51K
2024Q1
34
373.91K
18.23%
+170.33K
2023Q4
38
117.62K
5.71%
-262.96K
2023Q3
41
131.29K
7.90%
-1.54K
2023Q2
41
49.26K
2.96%
-111.70K
2023Q1
41
69.83K
4.25%
-82.42K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Alpha Capital Aktiengesellschaft
82.47K
3.19%
+49.29K
+148.54%
May 16, 2025
Armistice Capital LLC
39.88K
1.54%
+39.88K
--
Mar 31, 2025
UBS Financial Services, Inc.
5.16K
0.2%
+1.41K
+37.64%
Mar 31, 2025
Tower Research Capital LLC
1.01K
0.04%
+465.00
+84.55%
Mar 31, 2025
Morgan Stanley & Co. LLC
13.62K
0.53%
+13.62K
--
Mar 31, 2025
Fashek (Christopher M)
341.00
0.01%
--
--
May 16, 2025
Brown (Stephen Russell)
18.00
0%
--
--
May 16, 2025
Cassirer (Aurora)
9.00
0%
--
--
Mar 31, 2025
BofA Global Research (US)
7.00
0%
+4.00
+133.33%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
日付
種類
比率
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
KeyAI